Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
2022 will be our year
Hello Atlanta
is this place still ..... bad
Perk Labs Receives Mobile Payment Patent
by Perk Labs | 2021 November 9 | News | 0 comments
Vancouver, Canada / November 09, 2021 / Perk Labs Inc. (CSE: PERK) (OTCQB: PKLBF) (FKT: PKLB) (“Perk Labs” or the “Company”), the parent company of Perk Hero, the mobile commerce platform with perks on mobile payments, eCommerce, and digital gift cards, today announced the issuance of a new U.S. patent that protects the Company’s rights to one of its inventions for enabling the payments of invoices and bills using a mobile device. U.S. Patent No. 11,170,354 is the first patent issued to Perk Hero.
“We are pleased to enhance our intellectual property protection with this new patent issuance,” said Jonathan Hoyles, CEO, Perk Labs. “This new asset strengthens our licensing programs as we can now license patent-protected technology to potential licensees and franchisees. Ultimately, the grant of this patent symbolizes the underlying capabilities of Perk as an innovative technology disruptor.”
Perk Hero also has the following patent applications pending:
Canadian, Australian and European patent applications are pending for the above referenced invention for enabling the payments of invoices and bills using a mobile device
Canadian patent application is pending for another invention for enabling the payments of invoices and bills using a mobile device and wireless electronic transactions
S. and Canadian patent applications are pending for an invention that allows orders and payments initiated from traditional websites on any platform to be secured via mobile devices utilizing anti-fraud technology
S., Australian, Canada, and the UK patent applications are pending for an invention for transferring cryptographic tokens.
The Company anticipates that it will file additional patent applications as it continues to develop its innovative technology.
About Perk Labs Inc.
Perk Labs Inc. (CSE: PERK) (OTCQB: PKLBF) (FKT: PKLB) is the owner of Perk Hero, the mobile commerce platform on a mission to make shopping and dining experiences more engaging, convenient, and rewarding. Perk Hero is used to order and pay at restaurants, for online shopping and to buy digital gift cards from top brands. The platform features Shopify integration, contactless payments using Apple Pay, Google Pay, BitPay and Alipay, its own digital currency called Perk Coin, a gamified loyalty program, pre-order and pick up, and in-store payments with a QR code. Perk Hero is growing through a unique community-driven digital franchise business that is available to entrepreneurs at an attractive start-up price.
For more information about Perk Labs, please visit www.perklabs.io. Visit Perk Hero at www.perkhero.com. For more information on a Perk Franchise, visit www.perkfranchise.com.
For more information contact:
Jonathan Hoyles
CEO
Perk Labs Inc.
(833) 338-0299
investors@perklabs.io
Jordan Shafi
Account Manager
CHF Capital Markets
(416) 868-1079 x 233
jordan@chfir.com
Perk Labs Selects Solana and Provides Update on Cryptoreward Development Vancouver, Canada / October 21, 2021 / Perk Labs Inc. (CSE: PERK / OTCQB: PKLBF / FKT: PKLB) (“Perk” or the “Company”), the parent company of Perk Hero, the mobile commerce platform with perks on eCommerce, mobile payments and digital gift cards, today announced its plans to build its crypto loyalty reward with Solana, the fastest-growing ecosystem in crypto technology. Solana is a decentralized blockchain built to enable scalable, user-friendly apps. According to the Solana white paper, the Solana network could theoretically process 710,000 transactions per second (TPS) using a 1 gigabit per second network connection. According to the project’s website, the average transaction fee is $0.00025, far lower than the cost of the average Ethereum transaction at the time of this press release. Solana Labs, the company behind the network's software, raised more than $300 million in a token sale led by big-name investors such as Andreessen Horowitz and Polychain Capital. The price of Solana’s SOL token has soared this year as more and more teams decide to build their crypto projects on the Solana blockchain. The SOL token made its debut only 18 months ago and a year ago was worth less than $2 and as of yesterday traded at over U.S. $180. “Our goal is to build a crypto loyalty reward program that brings crypto to mainstream consumers by rewarding them for purchases made online and in brick & mortar establishments” said Jonathan Hoyles, CEO, Perk Labs. “After an extensive review of available options, we decided that the Solana blockchain’s high efficiency and low transaction fees provide the best foundation for our platform.” Perk will continue to work with the Jonah Group on the next phase of its cryptoreward loyalty program development, which will include digital wallet development, microservice API development, testing, smart contract development and deploying Perk’s cryptoreward on the Solana mainnet. In connection with the development of its cryptoreward, Perk will be incorporating new compliance tools and procedures and is working with a leading German Fintech design firm to update its mobile app with a state-of-the-art user interface to include additional reward features and game design elements. Subject to any unforeseen changes, Perk and Jonah estimate that Perk’s cryptoreward will be ready for deployment to the Solana mainnet by mid-January 2022. Perk will provide further updates as it makes progress on its cryptoreward development. Perk also recently announced its digital franchising program, with the intention to be the first franchise system that enables franchisees to leverage the power of blockchain technology. Perk Labs’ CEO Jonathan Hoyles will be presenting on the Perk Hero digital franchising opportunity at 2 pm EST on October 25, 2021 at the Canadian Franchise Association’s Virtual Franchise Canada Show. For more information on a Perk Franchise, visit www.perkfranchise.com. About Jonah Group Jonah Group is a custom software development company trusted by organizations that are faced with missioncritical business challenges and cannot afford to fail. Jonah Group has built several systems that process billions of dollars’ worth of transactions each year for clients who remain partners. Jonah has successfully developed and deployed a wide range of enterprise systems including online banking applications, equity and mutual fund trading systems, content management systems, credit adjudication and provisioning portals, health care benefits and claims management systems, and fleet management solutions. Its clientele includes many leading names in the financial services and health care industries.
chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/viewer.html?pdfurl=https%3A%2F%2Fsedar-filings.thecse.com%2F00038859%2F2110210535266424.pdf&clen=128960&chunk=true
[url]https://pro.ceo.ca/@accesswire/komo-plant-based-foods-plans-to-launch-ghost-kitchen
[/url][tag]insert-text-here[/tag]
by @accesswire on 27 Oct 2021, 12:00
Komo Plant Based Foods Plans to Launch Ghost Kitchen Concept through Komo Eats
VANCOUVER, BC / ACCESSWIRE / October 27, 2021 / Komo Plant Based Foods Inc. (CSE:YUM) (OTCQB:KOMOF) (FRA:9HB) ("Komo"), a premium plant-based food company, is pleased to announce that it is near completion of its Komo Eats menu for Komo's ghost kitchen concept, which will offer a selection of freshly made, hot and ready, plant-based comfort meals through on-demand delivery apps like DoorDash and Uber Eats.
Komo is planning to launch Komo Eats next month in Vancouver, British Columbia, where it can make and deliver meals out of its commercial kitchen, which is located close to downtown. The meals have been created using the same principles that were used to create Komo's signature plant based comfort foods - always easy, wholesome and hearty.
"At Komo, we're on a mission to make plant-based meals a staple and the launch of Komo Eats will be another avenue for us to share more hearty and wholesome plant-based favourites," says Komo operating subsidiary Komo Comfort Foods CEO Jeffrey Ma. "Our team who designed our frozen plant-based products is now finalizing the menu for Komo Eats. We are especially excited to build out this platform as an opportunity to innovate quickly and test out ideas that can potentially become retail products. We have many ideas but the challenge with commercializing products is the time and resources it requires and the uncertainty about whether consumers will embrace a new product in the marketplace. Komo Eats will allow us to get feedback early on to help mitigate this risk and learn about what our customers want. The bonus is that at the same time, we are sharing our mission and building our brand."
In addition to providing an additional revenue stream, Komo Eats will provide useful consumer and other data for product development for Komo's plant-based comfort foods. Other companies, like Upton's Natural and Amy's Kitchen have its Upton Breakroom and Amy's Drive Thru branches to complement their retail brand and products
Ghost kitchens are commercial kitchens that do not have a physical storefront that are used for food preparation and delivery. Komo's ghost kitchen will allow it to launch the Komo Eats brand across multiple delivery apps, generate revenues from food sales and increase its customer base without the costs associated with a restaurant or store front. The potential market for ghost kitchens is significant as, according to Statista, revenue in the restaurant-to-consumer delivery market is projected to reach US$4 Billion in 2021 in Canada alone, with a projected market volume of US$6 Billion by 2025.
https://www.statista.com/outlook/dmo/eservices/online-food-delivery/restaurant-to-consumer-delivery/canada
Komo expects many customers to engage with its Komo Eats digital storefront as their initial contact with the Komo brand. According to Skip the Dishes, the most popular food delivery Canada service, 81% of customers have ordered from a restaurant they have never visited in person. https://reviewlution.ca/resources/food-delivery-statistics
About Komo
Komo Plant Based Foods Inc. is a premium plant-based food company that develops, manufactures and sells a variety of plant-based frozen meals that are always hearty, satisfying, and made with wholesome ingredients. At Komo, our mission is to help make plant-based meals a staple on every dinner table by sharing our love for feel-good food that connects the people to the planet. We believe plant-based eating is the future and - Change can start with a single biteTM. Our experienced plant-based innovation and development team recreates vegan versions of traditionally cheesy and meaty classics, with 100% plants. Komo's products are sold direct-to-consumer through our eCommerce website and a distribution network of online and brick and mortar grocery, convenience and natural retailer channels. Our operating subsidiary Komo Comfort Foods launched in 2021 with our flagship products: plant-based Lasagna, Shepherd's Pie and Chickenless Pot Pie and has recently launched a new line - Komo Plant-Based Meal HelpersTM - versatile meal starters to allow the creation of many dishes at home. All of our products are 100% plant-based, made with wholesome ingredients, free from preservatives, and frozen for freshness. Freezing products is a natural and effective way of keeping food products for longer without having to use any preservatives. Komo's meals have a 1-year frozen shelf life.
Learn more at: www.komocomfortfoods.com and follow on Instagram: @komocomfortfoods
For further information, please contact:
William White, President & CEO, Komo Plant Based Foods Inc.
will@komoeats.com
1-866-969-0882
The Canadian Securities Exchange has not reviewed, approved or disapproved the contents of this news release.
by @accesswire on 27 Sep 2021, 14:30
Empower Clinics and SoLVBL Solutions Sign Memorandum of Understanding (MoU) to Develop a Program for Data Security in Diagnostic Testing
Enhanced Data Verification Will Augment Empower's Integrated Technology Services and Goals
VANCOUVER BC / ACCESSWIRE / September 27, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(FRA:8EC)(OTCQB:EPWCF) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens - is pleased to announce it has signed a Memorandum of Understanding with SoLVBL Solutions Inc. ("SoLVBL Solutions") to develop a cyber security program to detect cyber-attacks and provide data security to the diagnostic testing programs used by Empower.
SoLVBL Solutions is at the forefront of developing cybersecurity solutions and advanced unique capabilities for providing customers with capabilities to protect and verify incoming data against a range of cyber threats. The novel solution powered by SOLV's underlying technology, will incorporate dedicated data security mechanisms for Empower's diagnostic testing platform. As healthcare service providers face increased cybersecurity threats, the need for effective and resilient data security is paramount to maintain seamless healthcare services.
"We are excited to collaborate with SoLVBL Solutions, a company with broad know-how in data verification and cybersecurity. The collaboration agreement entered with Empower combines SoLVBL Solutions' data verification capabilities with Empower's experience and extensive expertise in the design, construction, operation, and maintenance of healthcare clinics and world-class diagnostic laboratories. With the increase in data collection, the demand to protect and verify data is unprecedented. We have seen such announcements come from both the Canadian and American governments. We feel this verification solution will allow us to continue to grow and meet the demands and needs of our patients and health care administrations. The collaboration aligns with our expansion and growth plans to become a global technological leader in the healthcare diagnostic sector." said Steven McAuley, CEO of Empower.
"We are extremely proud that SoLVBL Solutions' collaboration with Empower will yield a comprehensive cybersecurity solution for Empower's diagnostic testing platforms, answering a growing global cyber threat. We believe this will be the first of many such opportunities in the healthcare vertical, and one that we realized was needed and doable in our ongoing conversations with the Empower team. Together we realized the need for this level of data protection in this sector." said Raymond Pomroy, CEO of SoLVBL Solutions.
This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics
ABOUT SOLVBL SOLUTIONS INC.
SoLVBL Inc.™ takes a different approach to cybersecurity with its proprietary Q by SoLVBL™ protocol that quickly and cost-effectively establishes the authenticity of digital records at very high speed. We don't believe that any system is ‘un-hackable', no matter how secure it appears to be, and if a system can be hacked, the data within that system is subject to manipulation. Bad data leads to bad decisions. Our Mission: ‘To empower better, faster decisions by developing a universal standard for establishing digital record authenticity which is easy to adopt, cheap to use, offers cryptographic assurances, and will not bottleneck systems.'. The Company is currently pursuing the following verticals: chain of custody for digital evidence including NG-911; data used in the financial sector; medical applications; and critical IoT infrastructures.
ABOUT EMPOWER:
Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley
Chief Executive Officer
CONTACTS:
Investors:
Steven McAuley CEO
s.mcauley@empowerclinics.com 604-789-2146
Investors:
Tamara Mason
Business Development & Communications
t.mason@empowerclinics.com
416-671-5617
by @accesswire on 23 Sep 2021, 14:31
Empower Clinics Launches Its Next "The Medi-Collective" Clinic; Expands Pipeline of Clinics To 33 locations including Alberta, British Columbia, and New Brunswick
Empower Officially Enters National Clinic Rollout Phase Under The Medi Collective Brand
VANCOUVER, BC / ACCESSWIRE / September 23, 2021 / EMPOWER CLINICS INC. (CBDT:CSE) (EPWCF:OTCQB) (8EC:Frankfurt) ("Empower" or the "Company") an integrated healthcare company serving patients through medical centers, telemedicine platforms, a medical device company, and a high complexity medical diagnostics laboratory processing COVID-19 specimens and developing a variety of direct to consumer testing protocols, is pleased to announce the expansion of its national clinic rollout strategy with the expected grand opening of "The Medi-Collective" ("TMC") clinic in Etobicoke, Ontario on October 18th, 2021.
Furthermore, Empower is pleased to provide shareholders with an update on the progress of its Canadian nationwide clinic expansion strategy, which now includes a pipeline of 33 clinic locations at various stages of development, including our first clinic locations outside of Ontario.
SAVE THE DATE - SHAREHOLDERS INVITED TO OCTOBER 18TH GRAND OPENING CEREMONY IN ETOBICOKE, ONTARIO
On September 8th Empower announced the official opening of its inaugural TMC medical clinic in Hamilton, Ontario. On October 18th Empower shareholders are invited to the grand opening and ribbon cutting ceremony of our new TMC clinic at 440 Brown's Line, Etobicoke, ON M8W 3T9, which will include CEO Steven McAuley, Dr. Jordan Rabinowitz and Dr. Aviv Tsimerman, as well as VIP guests from the financial, medical, and political sectors.
Guests will have an opportunity to experience the 2,600 square foot clinic and meet the medical staff firsthand, to truly visualize the TMC model for expansion across Canada - all while enjoying great food, TMC swag, photo opportunities and conversations with Company management.
"I could not be more excited for our company and shareholders to see our investment in Brownsline and the City of Etobicoke come together and be fully open to serve patients." said Steven McAuley, Chairman & CEO Of Empower Clinics. "We are all living though challenging times, yet I have watched our outstanding team members be optimistic, persevere and never waiver from our goals. We are a collective, we care about our patients, the communities we serve, our shareholders, and we look forward to many more grand openings."
CLINIC PIPELINE UPDATED TO INCLUDE 33 LOCATIONS AND SPANNING 4 PROVINCES THANKS TO GREATER THAN EXPECTED DEMAND FROM DOCTORS AND PHARMACY PARTNERS. OPENINGS PROJECTED EVERY 3 WEEKS THROUGH THE END OF 2021 AND INTO Q1 2022
The Company is pleased to advise shareholders that our pipeline of clinics continues to expand rapidly, even more than anticipated, thanks to greater than expected interest from doctors and pharmacy partners who want to be involved with The Medi-Collective brand. This now extends beyond Ontario and into the provinces of:
Alberta
British Columbia
New Brunswick
The status of our clinic pipeline in Canada can be summarized as follows:
OPERATING - 3
IN DEVELOPMENT & CONSTRUCTION - 9
IN DUE DILIGENCE - 21
TOTAL - 33
Advanced discussions continue for additional locations nationwide, as the Company gains momentum on its Canadian roll out strategy.
"Our decision to align with pharmacy brands both national and independent across Canada is proving to be so beneficial. Together we support patients and people in the communities we serve. Together, we bring greater access to care, providing advanced specialist services under one roof, both in-clinic and through telemedicine and virtual care." Empowers Chairman & CEO Steven McAuley further states, "We are leveraging our R&D and product divisions to ensure people everywhere have more control over their personal healthcare outcomes. Wellness matters, it matters to me, it matters to our team members, it matters to our shareholders, it matters to our partners, it matters to the patients and communities we serve."
HEALTH CARE SERVICES TO BE DELIVERED AND ANTICIPATED REVENUES
Empower, though The Medi Collective division, is opening primary care and para-medical healthcare services in its clinics.
Primary care services include:
Family physicians
Walk-in physicians
Tele-medicine and virtual care
The Company anticipates it could generate $400,000 - $600,000 in annual revenue per MD, per location, which equates to a revenue range between $1,600,000 - $2,400,000 annually per location.
Paramedical services include:
Chiropractic
Physiotherapy
Registered Massage Therapy
Chiropody
Acupuncturists
Osteopaths
Nutritionists
The Company anticipates it could generate $960,000 - $1,200,000 in annual revenue per location with Paramedical services
When locations are fully operational, Empower anticipates it could generate $2,560,000 - 3,600,000 in annual revenue per location on a weighted average fully operational basis.
ADDITIONAL HEALTH CARE SERVICES EXPECTED TO BE ADDED
Given the anticipated rapid expansion and penetration of Empower and The Medi Collective brand into the Canadian market, the Company intends to continue adding valuable specialized medical services to strengthen the quality of healthcare at each location that can include:
Tele-Dermatology
On March 10th Empower and MedX Health Corporation (TSX-V: MDX) announced an MOU to pilot MedX's tele-dermatology screening platform at two select Empower Clinics locations in Ontario, with plans for a broader market roll-out pending the completion of a successful pilot.
Cardiology
Empower continues to have ongoing discussions with a variety of cardiology specialists and is reviewing cardiology product opportunities that the MediSure brand could bring to market.
The Company believes these additional services hold the potential to add significant value to the operations of each healthcare centre.
This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions, and engagement with management https://agoracom.com/ir/EmpowerClinics
ABOUT EMPOWER:
Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, a medical device company and a world-class medical diagnostics laboratory. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley
Chief Executive Officer
CONTACTS:
Investors:
Steven McAuley CEO
s.mcauley@empowerclinics.com
604-789-2146
Investors:
Tamara Mason
Business Development & Communications
t.mason@empowerclinics.com
416-671-5617
Empower Clinics Uplisted - Will Begin Trading on OTCQB Market
posted on Sep 10, 2021 10:50AM
Log in to use the IP Check tool [?]
OTCQB Market Provides Greater Access to Empower Shares in the U.S.
VANCOUVER BC / ACCESSWIRE / September 10, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens - announced today that its common shares will be added to the OTCQB Venture Market (the "OTCQB") at market open on September 10, 2021, under the symbol "EPWCF."
"This is an extremely exciting announcement for Empower's market presence in the U.S.," said Steven McAuley, Chairman and CEO of Empower Clinics. "Empower shares are now accessible to a trove of new U.S. based retail and institutional investors. This expanded visibility is a huge step forward as we continue our aggressive North American expansion in the integrated healthcare space."
The OTCQB is a well-regarded public financial market for international companies across a variety of sectors. It's an ideal next step for Empower Clinics as the market has a particular focus on entrepreneurial and fast-developing companies. The market's high financial and corporate standards speak to the progress of Empower Clinics. Following a rigorous approval process, successful companies receive access to a diversified base of U.S. retail and institutional investors in addition to the opportunity to increase the Company's visibility and liquidity.
Empower's shares will continue to be listed on the Canadian Securities Exchange (CSE) under the ticker symbol "CBDT," as well as on the Frankfurt Stock Exchange (FRA) under the ticker symbol "8EC." ?
This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics
ABOUT EMPOWER:
Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley
Chief Executive Officer
CONTACTS:
Investors:
Steven McAuley CEO
s.mcauley@empowerclinics.com
604-789-2146
Investors:
Tamara Mason
Business Development & Communications
t.mason@empowerclinics.com
416-671-5617
https://www.otcmarkets.com/stock/ASTI/security
ASTI SECURITY DETAILS
Share Structure
Market Cap Market Cap
286,078,310
09/09/2021
Authorized Shares
20,020,218,096
09/09/2021
Outstanding Shares
18,945,583,471
09/09/2021
Restricted
Not Available
Unrestricted
Not Available
Held at DTC
6,078,468,023
09/09/2021
Float
Not Available
Par Value
No Par Value
by @accesswire on 8 Sep 2021, 08:00
Empower Clinics Opens First of Many “TMC” Clinics in Canada
The Medi-Collective Clinic is Now Accepting New Patients & Walk-Ins in Hamilton, Ontario
VANCOUVER, BC / ACCESSWIRE / September 8, 2021 / EMPOWER CLINICS INC. (CBDT:CSE) (8EC:Frankfurt) (EPWCF:OTCQB) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, telemedicine platforms, a medical device company, and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens - is pleased to announce the official opening of The Medi-Collective ("TMC") inaugural medical clinic in Hamilton, Ontario.
"This is getting exciting, we are onto something special, The Medi-Collective, it's a launch!" said Steven McAuley, Chairman and CEO of Empower Clinics. "This is important, it opens more access for patients, it launches catalysts that we have talked about, allows us to kickstart the growth potential of TMC and Empower, just like I said we would do."
Dr. Jordan Rabinowitz, and Dr. Aviv Tsimerman added, "This location is a step in our strategic expansion of truly integrative care, based on patient-centric services. We are thrilled to be able to provide such comprehensive care to the Hamilton community. We are modernizing healthcare by having a team of professionals working together under one roof for the benefit of the patient."
As of today, the Hamilton, ON clinic is accepting new patients and walk-in appointments.
The Medi-Collective Hamilton Clinic
Address: 675 Rymal Rd E., Hamilton, ON L8W 1B5
Phone: 905-848-2441
Email: 675Rymal@themedicollective.com
This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics
ABOUT EMPOWER:
Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley
Chief Executive Officer
CONTACTS:
Investors:
Steven McAuley CEO
s.mcauley@empowerclinics.com
604-789-2146
https://pro.ceo.ca/@accesswire/empower-clinics-reports-1005-year-over-year-revenue
by @accesswire on 30 Aug 2021, 12:31
Empower Clinics Reports 1,005% Year-Over-Year Revenue Growth in Q2 2021
The Company Increased Its Cash Position and Paid Off $2 Million in Debt
VANCOUVER, BC / ACCESSWIRE / August 30, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(OTC PINK:EPWCF)(Frankfurt 8EC) (" Empower " or the " Company ") has filed today its consolidated financial statements and related management's discussion and analysis, both of which are available at www.SEDAR.com. All financial information in this press release is reported in United States dollars, unless otherwise indicated.
"Our second quarter was one of robust corporate development as we continue to execute our strategic growth vision while prioritizing the overall fiscal health of Empower Clinics," said Steven McAuley, Chairman and CEO. "By discontinuing certain operations in Q2, we paved the way for explosive growth across the company. We are excited about the R&D product development opportunities and increased testing available in Canada and the U.S. through the Kai Medical Laboratories expansion. We remain diligent on the progress of our Canadian clinic expansions and the distribution of MediSure devices. The entire Empower team is excited for the future."
Q2 2021 Highlights
Total revenues from continuing operations[1] of $861,826 for Q2 2021 compared to Q2 2020 revenues $85,775, representing 1005% year over year growth.
Cash at June 30, 2021 was $5,191,944 which increased from cash of $4,889,824 at December 31, 2020, primarily driven by the proceeds generated on exercise of share purchase warrants.
Cash used in operating activities of continuing operations was $416,949, compared to cash used of $171,848 for Q2 2020.
Loss from operations1 increased to $1,373,941 for Q2 2021 from $380,612 for Q2 2020, primarily driven by the increased corporate activity of the Company and legal and professional fees in pursuit of acquisitions.
Net loss from continuing operations1 of $412,209 or $0.00 per share compared to $501,419 or $0.00 per share for Q2 2020, which was primarily driven by a non-cash gain on the fair value adjustment related to the Company's warrants outstanding resulting from movement of the Company's share price (a key input in determining the fair value), offset by increased operating expenses.
Recent Highlights Subsequent to Quarter End
Sale of Sun Valley: In July 2021, the Company announced that it had entered into a non-binding agreement to sell its 100% ownership of Sun Valley to the previous owners of Sun Valley for total consideration of $1,000,000 payable in securities of Empower.
Acquisition : On July 30, 2021, the Company completed the acquisition of all ownership interest of Medi+Sure Canada Inc. for a total deemed purchase price of CAD$3.5M. Consideration consists of a cash payment of CAD$1,250,000 and 4,582,483 common shares of the Company, 2,036,659 of which are subject to contractual trading restrictions that will be removed quarterly over 24 months.
Common shares issued : The Company issued 21,176 shareswith a fair value of $0.41 (CAD$0.51) per share for proceeds of $9,023 (CAD$11,340) for marketing services and 125,000 shares from the exercise of stock options with an exercise price of $0.05 (C$0.06) for proceeds of $5,976 (CAD$7,500).
Financial Summary
US dollars, except where noted
Three months ended June 30,
2021 2020
Total revenues
861,826 85,775
Direct expenses
831,594 21,557
Loss from operations
1,373,941 380,612
Net loss from continuing operations
412,209 501,419
Net loss per share
- -
Financial Performance
Revenues for Q2 2021 and Q2 2020 were $861,826 and $85,775, respectively. This increase over prior year is attributable to the acquisition of Kai Medical and the strong revenue resulting from COVID-19 testing.
Direct expenses for Q2 2021 and Q2 2020 were $831,594 and $21,557, respectively. This increase over prior year is attributable to the acquisition of Kai which increased the Company's staffing levels and the ramp up of staffing as the Company expands its clinic presence in Canada through Lawrence Park & Atkinson.
Loss from operations for Q2 2021 and Q2 2020 were $1,373,941 and $380,612 respectively. This decrease from prior year is primarily attributable to the increase in revenues resulting from the acquisitions during fiscal 2020, offset by increased operating costs that are the direct result of consolidating the expenses of the acquired entities as well as the continued increase in corporate activity during Q2 2021 which increased legal and professional costs.
Net loss for Q2 2021 and Q2 2020 were $412,209 and $501,419, respectively. This decrease in loss over prior year is primarily attributable to the gain on change in fair value recognized on the warrant liability (as determined by the Black-Scholes option pricing model) which resulted from the decrease in the Company's share price between March 31, 2021 and June 30, 2021 and therefore the fair value allocated to warrants.
During Q2 2021, the Company used $416,949 in cash from continuing operations after changes in non-cash working capital. The Company invested $688,367 for the purchase of property and equipment and raised $258,336 via proceeds from various exercise of warrants and stock options, partially offset by lease payments and repayments of loans and notes payable in the amount of $104,483.
Please refer to the Company's condensed interim consolidated financial statements, related notes and accompanying Management Discussion and Analysis for a full review of the operations.
About Empower
Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.
ON BEHALF OF THE BOARD OF DIRECTORS: Steven McAuley
Chief Executive Officer
CONTACTS:
Tamara Mason
Business Development & Communications
416-671-5617
t.mason@empowerclinics.com
Steven McAuley
CEO
604-789-2146
s.mcauley@empowerclinics.com
https://pro.ceo.ca/@accesswire/empower-clinics-reports-1005-year-over-year-revenue
by @accesswire on 30 Aug 2021, 12:31
Empower Clinics Reports 1,005% Year-Over-Year Revenue Growth in Q2 2021
The Company Increased Its Cash Position and Paid Off $2 Million in Debt
VANCOUVER, BC / ACCESSWIRE / August 30, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(OTC PINK:EPWCF)(Frankfurt 8EC) (" Empower " or the " Company ") has filed today its consolidated financial statements and related management's discussion and analysis, both of which are available at www.SEDAR.com. All financial information in this press release is reported in United States dollars, unless otherwise indicated.
"Our second quarter was one of robust corporate development as we continue to execute our strategic growth vision while prioritizing the overall fiscal health of Empower Clinics," said Steven McAuley, Chairman and CEO. "By discontinuing certain operations in Q2, we paved the way for explosive growth across the company. We are excited about the R&D product development opportunities and increased testing available in Canada and the U.S. through the Kai Medical Laboratories expansion. We remain diligent on the progress of our Canadian clinic expansions and the distribution of MediSure devices. The entire Empower team is excited for the future."
Q2 2021 Highlights
Total revenues from continuing operations[1] of $861,826 for Q2 2021 compared to Q2 2020 revenues $85,775, representing 1005% year over year growth.
Cash at June 30, 2021 was $5,191,944 which increased from cash of $4,889,824 at December 31, 2020, primarily driven by the proceeds generated on exercise of share purchase warrants.
Cash used in operating activities of continuing operations was $416,949, compared to cash used of $171,848 for Q2 2020.
Loss from operations1 increased to $1,373,941 for Q2 2021 from $380,612 for Q2 2020, primarily driven by the increased corporate activity of the Company and legal and professional fees in pursuit of acquisitions.
Net loss from continuing operations1 of $412,209 or $0.00 per share compared to $501,419 or $0.00 per share for Q2 2020, which was primarily driven by a non-cash gain on the fair value adjustment related to the Company's warrants outstanding resulting from movement of the Company's share price (a key input in determining the fair value), offset by increased operating expenses.
Recent Highlights Subsequent to Quarter End
Sale of Sun Valley: In July 2021, the Company announced that it had entered into a non-binding agreement to sell its 100% ownership of Sun Valley to the previous owners of Sun Valley for total consideration of $1,000,000 payable in securities of Empower.
Acquisition : On July 30, 2021, the Company completed the acquisition of all ownership interest of Medi+Sure Canada Inc. for a total deemed purchase price of CAD$3.5M. Consideration consists of a cash payment of CAD$1,250,000 and 4,582,483 common shares of the Company, 2,036,659 of which are subject to contractual trading restrictions that will be removed quarterly over 24 months.
Common shares issued : The Company issued 21,176 shareswith a fair value of $0.41 (CAD$0.51) per share for proceeds of $9,023 (CAD$11,340) for marketing services and 125,000 shares from the exercise of stock options with an exercise price of $0.05 (C$0.06) for proceeds of $5,976 (CAD$7,500).
Financial Summary
US dollars, except where noted
Three months ended June 30,
2021 2020
Total revenues
861,826 85,775
Direct expenses
831,594 21,557
Loss from operations
1,373,941 380,612
Net loss from continuing operations
412,209 501,419
Net loss per share
- -
Financial Performance
Revenues for Q2 2021 and Q2 2020 were $861,826 and $85,775, respectively. This increase over prior year is attributable to the acquisition of Kai Medical and the strong revenue resulting from COVID-19 testing.
Direct expenses for Q2 2021 and Q2 2020 were $831,594 and $21,557, respectively. This increase over prior year is attributable to the acquisition of Kai which increased the Company's staffing levels and the ramp up of staffing as the Company expands its clinic presence in Canada through Lawrence Park & Atkinson.
Loss from operations for Q2 2021 and Q2 2020 were $1,373,941 and $380,612 respectively. This decrease from prior year is primarily attributable to the increase in revenues resulting from the acquisitions during fiscal 2020, offset by increased operating costs that are the direct result of consolidating the expenses of the acquired entities as well as the continued increase in corporate activity during Q2 2021 which increased legal and professional costs.
Net loss for Q2 2021 and Q2 2020 were $412,209 and $501,419, respectively. This decrease in loss over prior year is primarily attributable to the gain on change in fair value recognized on the warrant liability (as determined by the Black-Scholes option pricing model) which resulted from the decrease in the Company's share price between March 31, 2021 and June 30, 2021 and therefore the fair value allocated to warrants.
During Q2 2021, the Company used $416,949 in cash from continuing operations after changes in non-cash working capital. The Company invested $688,367 for the purchase of property and equipment and raised $258,336 via proceeds from various exercise of warrants and stock options, partially offset by lease payments and repayments of loans and notes payable in the amount of $104,483.
Please refer to the Company's condensed interim consolidated financial statements, related notes and accompanying Management Discussion and Analysis for a full review of the operations.
About Empower
Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.
ON BEHALF OF THE BOARD OF DIRECTORS: Steven McAuley
Chief Executive Officer
CONTACTS:
Tamara Mason
Business Development & Communications
416-671-5617
t.mason@empowerclinics.com
Steven McAuley
CEO
604-789-2146
s.mcauley@empowerclinics.com
http://crweworld.com/article/news-provided-by-accesswire/2108244/empower-clinics-and-pharmasave-enter-pilot-program-to-supply-kai-testing-to-independent-pharmacies
Empower Clinics and Pharmasave Enter Pilot Program to Supply Kai Testing to Independent Pharmacies
News Provided by Accesswire2021-08-2467 Views
FacebookTweetLinkedInRedditDiggVKontakteFlipboardEmailShareThis
The initial program will provide Kai COVID-19 Testing Solutions to hundreds of pharmacies across Canada
VANCOUVER, BC / ACCESSWIRE / August 24, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(FSE:8EC)(OTCQB:EPWCF) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens - has officially entered an Memorandum of Understanding ("MOU") for a six-month pilot program between Empower and Pharmasave for distribution and resale of Kai COVID-19 Testing Solutions. The products will include Rapid Antigen Testing, Rapid Antibody Testing and Kai Saliva RT-PCR tests.
"Tapping into Pharmasave's network is a huge step forward in our plan to provide Kai Testing solutions directly to consumers and further our national clinic expansion strategy," said Steven McAuley, Chairman and CEO of Empower Clinics. "With corporate pharmacy partners, PharmaChoice and now Pharmasave, we are seeing steady growth and momentum with a number of pharmacy groups from across North America."
With over 800 stores across the country, Pharmasave is one of Canada's leading independent pharmacy and drugstore retailers. Since being founded in 1981, Pharmasave has focused on building a national platform of community-based retail outlets designed to provide customers with exceptional service, products and advice. Each Pharmasave store operates independently to serve its individual community, which ensures both programs and services tailored to the needs of customers and a commitment to helping all customers. The company's local ties across numerous regions make it a great partner in providing direct consumer sales of Kai Testing Solutions. Empower hopes to build on this partnership through the national clinic expansion strategy and increase the quantity of services readily available to Canadians.
Under the MOU, Pharmasave and Empower agree to a six-month pilot program to allow both parties to evaluate the costs and revenue opportunities. It is the goal for this period to determine the final business model that will serve Pharmasave patients and their corporate accounts. Empower will provide Pharmasave with Health Canada Approved COVID-19 Testing Solutions (Rapid Antigen Testing, Rapid Antibody Testing and Kai Saliva RT-PCR tests), express shipping on all ordered units, and technical support.
This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics
ABOUT EMPOWER:
Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley
Chief Executive Officer
by @accesswire on 11 Aug 2021, 16:01
Empower Clinics Provides Corporate Update On National Clinic Expansion
Strong 2021 Fiscal Performance Supporting Robust Clinic, Testing Expansion and Acquisition Efforts
VANCOUVER, BC / ACCESSWIRE / August 11, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens - is pleased to provide the following corporate update on our national clinic expansion strategy and overview of other corporate endeavors.
"This corporate update is a testament to the growth of Empower Clinics over the last year," said Steven McAuley, Chairman & CEO of Empower. "Our national clinic expansion strategy will provide enhanced access to healthcare for millions of Canadians. We continue to make meaningful strides across our network with various Kai Care testing partnerships and its recent expansion allowing for greater volume and diversification of services. We are also thrilled to have completed the MediSure acquisition and look forward to leveraging our collective network to drive increased volume and new product development."
Clinic Pipelines
The Company is pleased to provide shareholders with an update on its progress of opening new clinics locations that are now in various stages ranging from LOI's, to leases signed, construction underway and opening dates pending.
SIGNED LEASES with construction underway
1) Etobicoke,ON
2) London, ON
3) Etobicoke, ON 2nd flagship location
4) Hamilton, ON
LEASES signed
1) Hamilton, ON Rexall proximity
2) Kitchener, ON Rexall proximity
3) Ajax, ON Rexall proximity
4) Barrie, ON Rexall proximity
PENDING LOI'S & LEASES
1) Sudbury, ON Pharmacy proximity
2) Chatham, ON Pharamcy proximity
3) Nepean, ON Pharmacy proximity
4) Peterborough, ON Pharmacy proximity
5) St. Catherines, ON
Chairman & CEO Mr. McAuley added, "I simply want to say that our Canadian health centre development plan has never been in doubt for us, from the moment we announced the strategy. Working so closely on a plan with pharmacy organizations takes time to materialize, it requires a collective effort with all constituents, but as everyone knows, we have not been idle, we have not been complacent, we have been diligent, respectful and focused on building a long-term strategy. I am so impressed with our business development team and their recruitment of medical doctors to date, that will serve so many communities and neighbourhoods. We seem to be building a collective of healthcare centers, a collective of medical professionals, a collective of knowledge and expertise, focused on the health outcomes of people in the markets we serve."
Acquisitions
Empower Clinics recently finalized the acquisition of leading Canadian diabetic service manufacturing company MediSure. With over $1.9M in revenue for 2020, 50,000 end users and presence in over 4,000 Canadian pharmacies, MediSure represents a highly valuable asset for the Empower Network.
Partnerships
Empower Clinics has signed nine partnership agreements in 2021 with leading companies across Canada and the United States. Each partnership leverages various strengths of the Empower Clinics network. The endeavours include:
Signed partnership to offer COVID-19 testing on a long-term basis for the Dallas Market Centre
Signed partnership for select clinics to offer the MedX DermSecure screening platform
Signed referral agreement with major Canadian airline for Kai Care COVID testing
Signed partnered with Loop Insights to augment COVID mitigation efforts through testing
Signed partnership with PharmaChoice to carry Kai Care saliva test kits, Antigen Tests & Antibody Tests in their more than 900 independent pharmacies across Canada
Signed partnership with Save-On-Foods to sell Kai Saliva tests in Vancouver area stores
Signed partnership with Tabula Rasa Pharmacy for a dedicated 24-hour customer support line
Financials
Empower Clinics has had a tremendous year of growth that has translated to promising fiscal results. A 58% year-over-year growth and a zero cash loss in 2020 set Empower up to make significant strides in 2021. Empower yielded over $2.5M of revenue in Q1 2021, a 258% growth compared to 2020.
Corporate Talent
Along with tremendous fiscal growth, Empower Clinics is looking to elevate its corporate leadership team and partnerships. Recently retained global executive recruiting firm Korn Ferry has started searching for a new Chief Financial Officer (CFO). An immediate priority for the new executive will be an in-depth review of current financial and audit operations, with the express intent to make recommendations to affect positive change on current practices and partnerships.
This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics
ABOUT EMPOWER:
Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley
Chief Executive Officer
CONTACTS:
Investors:
Steven McAuley CEO
s.mcauley@empowerclinics.com
604-789-2146
Investors:
Tamara Mason
Business Development & Communications
t.mason@empowerclinics.com
416-671-5617
ok, good luck
i had no chance in the 1: 1000 split and i tell you all he will be back and some of them will continue to have their fingers burned. I have nothing more to sell, I just want to warn.
I once had 20 million shares in ASTI, Atlanta1 knows it, they cost me a lot, no not a lot, but a lot of money! I can only warn everyone urgently. For me it means: once ASTI, never again ASTI ........... hands off !!!!
AS Logo.png
Ascent Solar Announces Second Quarter 2021 Financial Results
August 09, 2021 06:00 ET | Source: Ascent Solar Technologies,
...
THORNTON, CO, Aug. 09, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Ascent Solar Technologies, Inc. (OTC-PK: ASTI), a developer and manufacturer of state-of-the-art, lightweight, and flexible thin-film photovoltaic (PV) solutions, reported results for the quarter ended June 30, 2021.
Second Quarter 2021 Financial Summary:
Net revenue increased 660% to $0.38MM compared to $0.05MM in the second quarter of 2020.
Cost and expenses increased 470% to $2.14MM compared to $0.37MM in the corresponding quarter last year.
Net loss widened to $1.7MM, an increase of 25% compared to a net loss of $1.36MM in the second quarter of 2020.
Net loss included non-cash gain of approximately $0.23MM from the extinguishment of certain liabilities associated with subsidiaries, offset by $0.17MM of accrued cash and non-cash interest expense.
As reported previously, the Company was predominantly in a dormant status in the first nine months of 2020 due to financial constraints and COVID-19. After a series of restructuring and recapitalization activities which began in June 2020, the Company materially restarted its operations in October 2020, which resulted in increased revenue as compared to the same period last year.
Net revenue in the second quarter increased by $0.22MM, or 130%, from $0.17MM in the first quarter of 2021, which brings our year-to-date net revenue to $0.55MM, compared to full year net revenue of $0.07MM and $0.64MM in 2020 and 2019, respectively.
Cash and cash equivalents have also improved from a balance of $0.17MM as of December 31, 2020, to $1.36MM for the period ended June 30, 2021. Net working capital also improved from ($8.37MM) as of December 31, 2020 to ($0.78MM) for the period ended June 30, 2021. Most notably, the Company has reduced total liabilities by $11.59MM, down from $27.56M as of December 31, 2020 to $15.97MM at the close of this reporting period.
Management Comments:
“We continued to make great progress, both financially and operationally,” said Mr. Victor Lee, President and CEO of Ascent Solar Technologies, Inc. “Since the fourth quarter of 2020, the Ascent team restarted a dormant facility, regained current SEC reporting status, and began to deliver backlog orders. Despite setbacks caused by various challenges including the lack of financial resources and the impact of COVID-19 in 2020, the team demonstrated great resiliency and is excited and stand ready to get back to regular production mode,” continued Mr. Lee.
Mr. Lee concluded, “We will build on the successful delivery of a large order in the second quarter and continue to work on improving results going forward. The additional $10MM funding commitment from our controlling shareholder as announced on August 5, 2021 will enable Ascent to continue to execute our business plan. We are optimistic and certainly look forward to stronger years ahead, as we begin to execute our focused strategy in the high-value PV market. We will update our shareholders as we make continued progress.”
ABOUT ASCENT SOLAR TECHNOLOGIES, INC.:
Ascent Solar Technologies, Inc., is a developer of thin-film photovoltaic modules using flexible substrate materials that are more versatile and rugged than traditional solar panels. Ascent Solar modules were named as one of the top 100 technologies in both 2010 and 2015 by R&D Magazine, and one of TIME Magazine's 50 best inventions for 2011. The technology described above represents the cutting edge of flexible power and can be directly integrated into consumer products and off-grid applications, as well as other aerospace applications. Ascent Solar is headquartered in Thornton, Colorado, and more information can be found at www.AscentSolar.com.
Forward-Looking Statements:
Statements in this press release that are not statements of historical or current fact constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause the Company's actual operating results to be materially different from any historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements that explicitly describe these risks and uncertainties, readers are urged to consider statements that contain terms such as "believes," "belief," "expects," "expect," "intends," "intend," "anticipate," "anticipates," "plans," "plan," to be uncertain and forward-looking. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the Company's filings with the Securities and Exchange Commission.
Ascent Solar Technologies
Investor Relations: IR@AscentSolar.com
Ascent Solar Technologies Could Be On Its Last Leg
Jun. 15, 2021 7:45 AM ETAscent Solar Technologies, Inc. (ASTI)20 Comments1 Like
Summary
ASTI and its solar panel business have been struggling for years. In Q1, the company suffered another EBITDA loss.
Cash burn was $2 million. A capital raise helped increase cash to nearly $4 million.
At its current cash burn rate, ASTI could run out of liquidity by year end. Sans more capital, ASTI may not survive.
ASTI could be on its last leg. Sell the stock.
This idea was discussed in more depth with members of my private investing community, Shocking The Street. Learn More »
Learn More »
https://seekingalpha.com/article/4434867-ascent-solar-technologies-could-be-on-its-last-leg
including the GLANCE period, I have held the share that has now become PERK for 5 years. Through targeted subsequent purchases, now a seven-digit number of shares. Wish everyone the same perseverance, patience and, of course, good luck.
I believe in success and wait too........
https://ceo.ca/@accesswire/perk-labs-reports-second-quarter-2021-results
by @accesswire on 29 Jul 2021, 14:30
Perk Labs Reports Second Quarter 2021 Results
This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated February 17, 2021 to its short form base shelf prospectus dated July 17, 2020.
VANCOUVER, BC / ACCESSWIRE / July 29, 2021 / Perk Labs Inc. (CSE:PERK)(OTCQB:PKLBF)(FKT:PKLB) ("Perk Labs" or the "Company") the parent company of Perk Hero, the mobile commerce platform with exclusive perks on curated lifestyle products and digital gift cards, today announced financial results for the second quarter ended May 31, 2021.
Overview
During the second quarter, Perk Hero iterated on its platform with the release of a universal shopping cart, a proprietary payout system and multiple optimizations for users. These upgrades were a top priority for the Company in order to allow customers to shop simultaneously from a variety of brands and retailers on Perk Hero and to improve controls, insights and reporting functionality with respect to merchant payouts. A number of user interface upgrades were made to optimize navigation and checkout functionality.
The Company also hired Michelle Berg as Director of Marketing to help scale customer demand and acquisition as well as lead the Company's branding, messaging and communications strategy. Previously, she was a group lead at Major Tom, an industry leading marketing agency.
"Perk Hero has a unique marketplace with products and gamified digital rewards that appeals to today's shoppers," said Ms. Berg. "I am excited to help build the Perk Hero brand and raise awareness to this new marketplace through data-driven digital marketing campaigns."
The Company continues to prudently manage its working capital with $1.9 million cash on its balance sheet and $2.0 million in marketable securities. This has allowed us to invest more into research and development and accelerate our marketing efforts which we will continue to optimize in the coming quarters.
"We enter the second half of 2021 with a significantly improved and upgraded platform that empowers eCommerce merchants and restaurants with an omnichannel ecosystem that connects their offline business to their digital operations in a simplified way", said Jonathan Hoyles, CEO, Perk Labs. "One of our top priorities now is to grow customer demand for our merchants by providing consumers with a convenient and highly incentivized way to earn cryptocurrency by simply making purchases through our platform. We are also excited with the prospects of new revenue opportunities such as the licensing agreement with Century Services, which we believe provides a model we can replicate in other cities to expand our business across North America."
As at May 31, 2021, Perk Hero had 109 restaurants and 128 third-party sellers on its platform with a total of 7,382 products and 91 gift card brands for sale.
2021 Q2 Financial Highlights:
Working capital of $3.0M in Q2 2021 compared to $1.9M in Q2 2020 and $792k in Q4 2020.
Net loss of $1.3M in Q2 2021 compared to a net loss of $1.2M in Q2 2020.
Revenue of $1,085 in Q2 2021 compared to revenue of $1,811 in Q2 2020. Revenue in Q2 2021 consisted primarily of third-party seller transactions which is recognized on a net basis as compared to prior quarters in which the Company sold products from inventory which is recognized on a gross basis. For Q2 2021, the Company's focus was on improving its platform and checkout process and working on a number of overall quality improvements that were required after implementing upgrades. As such, consumer marketing initiatives were delayed to subsequent quarters until the upgrades and enhancements were complete.
General and administration expenses decreased 24% to $295k in Q2 2021 compared to $386k in Q2 2020 as the Company continued to practise cost discipline.
Research and development expenses increased 16% to $204k in Q2 2021 compared to $176k in Q2 2020 as the Company continues to invest in its technology platform.
Sales and marketing expenses increased 8% to $184k in Q2 2021 compared to $170k in Q2 2020 as the Company continues to test and refine its marketing efforts to maximize return on ad spend.
2021 Q2 Operational Highlights
Strengthened the balance sheet: During the six months ended May 31, 2021, the Company issued 15,641,000 common shares through its at-the-market offering filed July 29, 2020 at an average price of $0.10 per share for gross proceeds of $1,570,780. Commissions paid were $47,123 for net proceeds of $1,523,657.
The Company also issued 6,072,000 common shares through its at-the-market offering filed February 17, 2021 at an average price of $0.12 for gross proceeds of $709,085 and net proceeds of $687,813. As part of the offering, the Company paid commissions of $21,272.
Expanded relationship with InComm: The Company signed an agreement with InComm Payments to distribute digital gift cards in the United States. Gift card categories available through the Perk Hero app in the US include online shopping, streaming services, gaming, home improvement and major restaurant chains. Perk has developed an innovative platform for the sale of digital gift cards, allowing users to buy for themselves, send to friends as gifts, save the digital gift card in the Perk digital wallet as stored value, earn cash back rewards on the purchase of digital gift cards, and earn rewards for referring digital gift cards to friends and family.
Highlights Subsequent to 2021 Q2
Implemented a merchant referral program and streamlined merchant onboarding : The Company implemented a merchant referral program whereby people could receive a referral bonus for each successful merchant added to Perk Hero. Paired with Perk Hero's streamlined onboarding process, this will enable the Company to add additional merchants to its platform more quickly.
Initiated development of web-based portal : The Company initiated development of a new web-based internal administration portal that provides its team with more advanced reporting and data analytics and allows it to strengthen and broaden Perk's internal controls. This is an important tool to be able to analyze the growth of Perk's business and will be used to configure promotions and the way products and brands are displayed on the app. This internal web-based tool will also form the foundation for a new web-based merchant tool that will provide third-party sellers and restaurants on Perk's platform with data analytics, catalogue management, and other promotional and sales features.
Launched a new channel partner program : Perk Labs signed a reseller agreement with Century Services as its first partner in the program. Under the terms of the agreement, the Company will receive a recurring annual fee in addition to a percentage share of transaction fees. Century will have exclusive reseller rights for the restaurant vertical in the Greater Vancouver region and Perk will provide technical support. To support this new channel partner program, the Company has begun development of a new web-based restaurant ordering tool that is expected to be in high demand from restaurants, many of which are currently experiencing labour shortages.
Outlook
The Company's strategic priorities for the remainder of 2021 include:
Consumer marketing initiatives including digital marketing through programmatic advertising, search engine marketing, improving SEO, advertising on social media channels, influencer marketing, promoting special offers through email, push notifications, and SMS, exhibiting at special events, pop up shop, and product led growth initiatives including Perk Coin incentives for referrals, brand and product reviews, leaderboard status and badges.
Continued development of the Perk Hero product through a series of build-measure-learn iterations and expanding upon its omnichannel commerce capabilities.
Investor relations initiatives including video updates for investors, hosting investor webinars, taking part in roadshows to meet new investors and attending industry events.
Continuing to add useful spending tools that build upon Perk's existing platform, including enabling customers to make purchases using digital wallets and cryptocurrency.
Developing Perk Coin as a blockchain-based digital loyalty reward currency and exploring the conditions and requirements to distribute Perk Coin as a cryptocurrency.
The Company's complete financial results are available in its Consolidated Financial Statements and Management's Discussion and Analysis for the quarter ended May 31, 2021, each filed with Canadian securities regulators at www.sedar.com .
IFRS
The operational and financial information in this release is based on the consolidated figures in accordance with International Financial Reporting Standard (IFRS).
About Perk Labs
Perk Labs Inc. is the owner of Perk Hero , a digital loyalty management platform that enables merchants to provide their customers with digital rewards and a more engaging and convenient customer experience.
For more information about Perk Labs, please visit www.perklabs.io. Visit Perk Hero at www.perkhero.com.
For more information, please contact:
Norman Tan
Chief Financial Officer
norman@perkhero.com
833-338-0299
investors@perklabs.io
CHF Capital Markets
Iryna Zheliasko, Manager, Corporate Communications
416-868-1079 x 229
iryna@chfir.com
by @accesswire on 16 Jul 2021, 14:30
Perk Labs Provides Corporate Update
VANCOUVER, BC / ACCESSWIRE / July 16, 2021 / Perk Labs Inc. (CSE:PERK)(OTCQB:PKLBF)(FRA:PKLB) ('Perk' or the 'Company'), the parent company of Perk Hero, the mobile commerce platform with perks on curated specialty products, mobile payments and digital gift cards, today provided a corporate update.
Highlights:
Multiple technology updates and bug fixes to offer the best app experience for customers and merchants
Improved internal reporting system to stimulate business growth and provide better data analytics
Additional cybersecurity measures to combat fraudulent transactions
Adding new products and merchants through new agreements with large dropshipping suppliers
Developing a new licensing business model with the aim of providing high-margin annual licensing revenue
Road map includes upgrading Perk Coin into a blockchain-based digital reward
Perk Labs CEO Jonathan Hoyles comments:
'Our vision for Perk Hero is ambitious in scope and that is why we've made upgrades to our platform this year which include our new web app, multicurrency capabilities, universal shopping cart, and a proprietary payout system. After our recent upgrade of Perk's shopping cart and payout system, a number of overall quality improvements and fixes were required to optimize the customer experience for our users. We continue to diligently work on these fixes to ensure a seamless experience for customers.
We've benchmarked our navigation and checkout against some of the most successful internet companies to improve our checkout experience and reduce cart abandonment. We continue to analyze our data and iterate to optimize our customer experience.
We have developed new anti-fraud tools and procedures to prevent fraudulent transactions. This is an important step to scale up our digital gift card offering and adoption of blockchain technology, as digital gift cards and cryptocurrency are often a target for fraud.
We have also been building a new web-based internal administration portal that provides our team with more advanced reporting and data analytics and allows us to strengthen and broaden our internal controls. This is an important tool for us to analyze the growth of our business and will be used to configure promotions and the way products and brands are displayed on our app. This internal web-based tool will also form the foundation for a new web-based merchant tool that will provide third-party sellers and restaurants on our platform with data analytics, catalogue management, and other promotional and sales features.
Platform improvements have been our top priority until now, and with all the recent upgrades completed, we are in a much better position to concentrate on consumer marketing moving forward.
We continue to add new merchants and products to our platform. We've recently connected our platform to some large dropshipping suppliers which has allowed us to increase our product shelf by over 600 items in the last month. We will continue to add more items from these and similar suppliers. We also recently added Delta Airlines and Subway Restaurants to our digital gift card offering and plan to add more digital gift cards in the near future.
We have also been working closely with Century Service to ensure the mutual success of our partnership and to develop a licensing business model that can be replicated in other cities. This licensing model has the potential to provide high-margin annual licensing revenue. We believe that by combining our unique assets with the specialized expertise of our partners we will enable both Perk and our partners to grow most efficiently and quickly in order to serve more customers daily. One of the tools we are developing for this business line is a lite web-based ordering tool so that restaurant customers can order from their table using their phone's browser. Customers will then be prompted to download our app to earn digital loyalty rewards on future purchases.
Looking forward, we are in the process of planning updates to our product roadmap as the business environment rapidly changes with the easing of pandemic restrictions. We are now seeing a new trend in consumer behaviour as consumers are spending more on restaurants, travel and experiences and less on purchasing items for their homes. Brands are now more than ever focused on designing and delivering seamless integrated experiences for their customers across multiple channels. On top of that, many businesses, especially restaurants, are experiencing a labour shortage as the workforce for certain industries has moved on to other areas. The pandemic has also accelerated consumer adoption of eCommerce, QR code mobile payment and cryptocurrency. We believe that the investments we have made in our platform position us well for the future as the online and offline worlds become one and our platform will be a great solution for offline businesses that are looking for ways to use technology to alleviate the worker shortage. One of our top priorities for this year will be to upgrade Perk Coin to a blockchain-based digital reward. We believe that customers will be much more incentivized by non-breakable, distributed rewards earned via smart contracts that can be accessed in a digital wallet and exchanged for other items of value. We will be providing further updates on our product roadmap and development of Perk Coin in the near future.'
Perk's goal is to build out an everyday app that offers shopping, food ordering and mobile payments, and the Company is focused on creating a seamless experience and unlocking value for its customers by offering complementary services on a single platform with digital loyalty rewards at its core.
About Perk Labs Inc.
Perk Labs Inc. (CSE: PERK) (OTCQB: PKLBF) (FKT: PKLB) is the owner of Perk Hero, the mobile commerce platform on a mission to make shopping and dining experiences more engaging, convenient, and rewarding. Perk has partnered with vetted specialized brands across North America. Consumers can also buy digital gift cards from top merchants that include gaming and electronics, apparel, dining, and more. The Perk Hero platform, currently available in Canada and the US, was engineered for reliability and scale using enterprise-level technology fit for businesses of all sizes. The platform also features Shopify integration, contactless payments using Apple Pay, Google Pay, BitPay and Alipay, as well as its own digital currency called Perk Coin, a gamified loyalty program, e-commerce dropshipping capabilities, pre-order and pick up, and in-store payments with a QR code.
For more information about Perk Labs, please visit www.perklabs.io. Visit Perk Hero at www.perkhero.com.
For more information contact:
Jonathan Hoyles, CEO
Perk Labs Inc.
(833) 338-0299
investors@perklabs.io
Iryna Zheliasko, Manager, Corporate Communications
CHF Capital Markets
416-868-1079 x 229
iryna@chfir.com
https://pro.ceo.ca/@accesswire/perk-labs-announces-agreement-with-century-restaurant
by @accesswire on 8 Jun 2021, 14:32
Perk Labs Announces Agreement with Century Restaurant Group and New Channel Partner Program
VANCOUVER, BC / ACCESSWIRE / June 8, 2021 / Perk Labs Inc. (CSE:PERK)(OTCQB:PKLBF)(FRA:PKLB) ("Perk" or the "Company"), the parent company of Perk Hero, the mobile commerce platform with perks on curated specialty products and digital gift cards, today announced that it has launched a reseller program for its restaurant payment solution and that Century Restaurant Group has signed an agreement to be its first reseller partner.
"We are excited to launch our new reseller program with Century Restaurant Group joining us as our first partner in the program,' said Jonathan Hoyles, CEO of Perk Labs. "We believe that our reseller program will be key to our ability to scale and distribute our restaurant mobile ordering, payment and digital loyalty solution across the North American continent."
Perk believes that its reseller program offers companies and individuals a lucrative income-generating opportunity in the rapidly growing business of digital payments and ordering. Under the reseller program, resellers have the right to sell Perk's restaurant ordering and payment solution to restaurants and receive a share of the revenue received on every order. Perk's restaurant solution includes QR code payment, PayByPhoto, order from table, pre-order and pick-up, self-managed delivery and Perk's proprietary digital loyalty program. By working with resellers, Perk will be able to scale up its business without having to hire a large sales and operations workforce that would be required to physically support brick & mortar restaurants across North America.
"We are excited to partner with Perk and bring its innovative ordering and payment solution to the restaurant industry," said Justin Strange, President of Century Restaurant Group. "I believe that ordering and paying directly through your mobile device while sitting at your table is the future for restaurants and the time is right to bring this solution to the market as restaurants begin to re-open following the pandemic restrictions lifting."
Pursuant to the terms of the agreement with Century, Perk will receive a recurring annual fee in addition to a percentage share of transaction fees. Century will have exclusive reseller rights for the restaurant vertical in the Greater Vancouver region and Perk will provide technical support. The agreement also includes a minimum sales target for Century to achieve over a three-year period.
Perk also announced today that Amazon.ca digital gift cards are now available on its platform in Canada. Amazon.ca digital gift cards can be purchased by using Perk Coins, which are earned by making purchases on Perk Hero.
About Century Restaurant Group
Century Restaurant Group DBA "Century Service" was founded in 2019 by Justin Strange and his team with the goal of bringing a focused digital solution to dine-in restaurants. Century's model allows customers control over their dining experiences by initiating instant ordering and payment solutions right from their phone - something customers have come to expect with the latest food ordering technologies gaining popularity. Century is excited to pair hospitality professionals with technology that will bring a seamless digital dine-in experience to complement the current model and aid in the recovery of the hospitality industry caused by the pandemic.
About Perk Labs Inc.
Perk Labs Inc. (CSE:PERK)(OTCQB:PKLBF)(FRA:PKLB) is the owner of Perk Hero, the mobile commerce platform on a mission to make shopping experiences more engaging, convenient, and rewarding. Perk has partnered with vetted specialized brands across North America to bring its customers products that are eco-friendly, natural, organic, and ethically sourced. Consumers can also buy digital gift cards from top merchants that include gaming and electronics, apparel, dining, and more. The Perk Hero platform, currently available in Canada and the U.S., was engineered for reliability and scale using enterprise-level technology fit for businesses of all sizes. The platform also features Shopify integration, contactless payments using Apple Pay, Google Pay, BitPay and Alipay, as well as its own digital currency called Perk Coin, a gamified loyalty program, e-commerce dropshipping capabilities, pre-order and pick up, and in-store payments with a QR code.
For more information about Perk Labs, please visit www.perklabs.io. Visit Perk Hero at www.perkhero.com.
For more information, contact:
Jonathan Hoyles
CEO
Perk Labs Inc.
(833) 338-0299 investors@perklabs.io
Iryna Zheliasko, Manager, Corporate Communications
CHF Capital Markets
416-868-1079 x 229
iryna@chfir.com
by @accesswire on 7 Jun 2021, 10:30
Empower Clinics Signs Six Agreements for New Clinic Locations with National Pharmacy Group
Clinic buildouts to commence in Ontario, Canada with annualized revenues for the six locations estimated between $12 million and $18 million CAD
VANCOUVER, BC / ACCESSWIRE / June 7, 2021 / EMPOWER CLINICS INC. (CBDT:CSE) (8EC:Frankfurt) (EPWCF:OTCQB) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens - is pleased to announce the signing of six Letters of Intent (LOI's) to open medical healthcare centers with REXALL/PHARMA PLUS PHARMACIES LTD the second largest pharmacy group in Canada.
It is proposed that Empower will act as a subtenant for these initial six locations to build and operate health care centers as a key driver of Empower's national clinic expansion strategy. Services include full primary care led by medical doctors plus paramedical services with practitioners providing services including chiropractic care, physiotherapy and more. Beneficiaries of these services include the pharmacies large existing customer base in addition to patients in the wider communities each location will serve.
Using Empower's expertise in physician recruitment and clinic management, these clinics are estimated to serve thousands of patients per location once fully constructed, with four to six medical doctors and healthcare practitioners per location, respectively.
"With estimated annual revenues of $2,000,000 - $4,000,000 per location, it's not an understatement to call this a big acceleration of our game-changing growth strategy for both our patients and shareholders." said Steven McAuley, Chairman & CEO of Empower Clinics. "Working with national pharmacy brands both in Canada and the U.S. is proving to be the correct strategy, the correct plan, the correct path forward."
PROPOSED NEW CLINIC LOCATIONS
117B Cedar St. Sudbury, Ontario (3900 square ft)
350 Cresthaven Dr. Ottawa, Ontario (1500 square ft)
3701 Lakeshore Blvd W. Toronto, Ontario (1800 square ft)
401 St. Clair Street Chatham, Ontario (2500 square ft)
85 George St. N. Peterborough, Ontario (2000 square ft)
3 N Service Rd. St. Catharines, Ontario (2500 square ft)
HEALTH CARE SERVICES TO BE DELIVERED
Empower will be opening primary care and para-medical healthcare services in its various locations.
Primary care services include:
Family physicians
Walk-in physicians
Tele-medicine and virtual care
Paramedical services include:
Chiropractic
Physiotherapy
Registered Massage Therapy
Chiropody
Acupuncturists
Osteopaths
Nutritionists
ADDITIONAL HEALTH CARE SERVICES EXPECTED TO BE ADDED
Given the expansion and penetration of Empower Clinics into the Canadian market, the Company intends to continue adding valuable specialized medical services to strengthen the quality of healthcare at each location that can include:
Tele-Dermatology
Cardiology
This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics
ABOUT EMPOWER:
Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley
Chief Executive Officer
CONTACTS:
Investors:
Steven McAuley CEO
s.mcauley@empowerclinics.com
604-789-2146
Investors:
Tamara Mason
Business Development & Communications
t.mason@empowerclinics.com
416-671-5617
It is and will remain a scam company
Hi LAO lol
by @accesswire on 29 Apr 2021, 14:31
Perk Labs Reports First Quarter 2021 Results
VANCOUVER, BC / ACCESSWIRE / April 29, 2021 / Perk Labs Inc. (CSE:PERK)(OTCQB:PKLBF)(FKT:PKLB) ("Perk Labs" or the "Company") today announced financial results for the first quarter ended February 28, 2021.
Overview
The Company enters the new fiscal year with a significantly strengthened balance sheet due to the success of its at-the-market offerings coupled with the IPO of Euro Asia Pay. As at February 28, 2021, the Company had $2.1 million cash, $2.8 million in marketable securities and zero long term debt. This strength in its balance sheet provides Perk Hero with the resources required to execute on its plan.
During the first quarter, Perk Hero expanded its marketplace offerings into the US market which is over ten times the size of the Canadian market. It expanded its partnership with InComm Payments to offer digital gift cards in the United States and developed a Shopify integration that enables merchants to onboard the Perk Hero platform more quickly and efficiently.
"Our strong balance sheet enables us to scale up our marketing efforts which we believe will drive growth in the number of users and merchants," said Perk CFO Norman Tan. "Our investments in these areas will create value for our company and drive future results."
Jonathan Hoyles, Perk Labs CEO, said: "I am excited about the marketing resources that we have onboarded and look forward to scaling up. We have continued to improve our product and we now have a complete omnichannel package that can help small businesses across the continent. This sets the foundation for our future success."
2021 Q1 Financial Highlights:
Net income of $1.6M in Q1 2021 compared to a net loss of $1.2M in Q1 2020.
Working capital of $3.5M in Q1 2021 compared to $2.8M in Q1 2020 and $785k in Q4 2020.
General and administration expenses decreased 11% from $306k in Q1 2020 to $272k in Q1 2021 as the Company continued to practice cost discipline.
Research and development expenses increased 15% from $146k in Q1 2020 to $169k in Q1 2021 as the Company continues to invest in its technology platform.
Sales and marketing expenses increased 4% from $157k in Q1 2020 to $162k in Q1 2021 as the Company continues to test and refine its marketing efforts.
2021 Q1 Operational Highlights
Launched a new web app: The Company launched a new web app located at Perkhero.com that enables users to make purchases and receive rewards using their desktop or mobile web browser. This new web app syncs directly with the Perk Hero database and allows for a true omnichannel experience. Furthermore, it allows the Company to build a large web presence that will help with search engine optimization and marketing campaigns.
Entered the US market: Multi-currency support was added to the Perk Hero platform that enables users from the US to shop from existing Perk Hero merchants. The eCommerce market in the United States is more than ten times the size of Canada's, representing a great opportunity for the acceleration of the Company's growth.
Developed a Shopify integration: The Company created a custom Shopify application that allows merchants to quickly onboard the Perk Hero platform and seamlessly import their products. In addition, orders placed through the Perk Hero platform are automatically synchronized with the merchants' Shopify stores, which allows for a streamlined workflow for fulfilment.
Renewal of at-the-market offering: On February 17, 2021, the Company announced the renewal of its at-the-market equity program following the successful conclusion of the previous program filed July 29, 2020. The renewed offering allows the Company to issue and sell up to $4,000,000 worth of common shares in the capital of the Company from treasury to the public from time to time. Between December 1, 2020 and April 28, 2021, the Company raised a total of $2.1M through its at-the-market equity programs.
Euro Asia Pay IPO: On February 25, 2021, Euro Asia Pay Holdings Inc. completed its initial public offering of shares at a price to the public of $0.25 per share. Perk Labs owns 8,500,000 shares of Euro Asia Pay which it received as part of a licensing agreement dated October 14, 2017, as amended on September 30, 2018.
Outlook
The Company's strategic priorities for the remainder of 2021 include:
Investments into sales and marketing to drive significant merchant and user growth on the Perk Hero Platform.
Continued development of the Perk Hero product through a series of build-measure-learn iterations and expanding upon its omnichannel commerce capabilities.
Developing communication strategies that speak to key customers with focused messages in the relevant channels in addition to addressing broader brand communications.
Continuing to add useful spending tools to Perk's roadmap that build upon an existing platform, including enabling customers to make purchases using digital wallets and cryptocurrency.
The Company's complete financial results are available in its Consolidated Financial Statements and Management's Discussion and Analysis for the quarter ended February 28, 2021, each filed with Canadian securities regulators at www.sedar.com.
IFRS
The operational and financial information in this release is based on the consolidated figures in accordance with International Financial Reporting Standard (IFRS).
About Perk Labs Inc.
Perk Labs Inc. (CSE:PERK)(OTCQB:PKLBF)(FKT:PKLB) is the owner of Perk Hero, the mobile commerce platform on a mission to make shopping experiences more engaging, convenient, and rewarding. We've partnered with vetted specialized brands across North America to bring our customers products that are eco-friendly, natural, organic, and ethically sourced. Consumers can also buy digital gift cards from top merchants that include gaming and electronics, apparel, dining, and more. The Perk Hero platform, currently available in Canada and the US, was engineered for reliability and scale using enterprise-level technology fit for businesses of all sizes. The platform also features Shopify integration, contactless payments using Apple Pay, Google Pay and Alipay, as well as its own digital currency called Perk Coin, a gamified loyalty program, e-commerce dropshipping capabilities, pre-order and pick up, and in-store payments with a QR code. For more information about Perk Labs, please visit www.perklabs.io.
Visit Perk Hero at www.perkhero.com
For more information, please contact:
Norman Tan
Chief Financial Officer
norman@perkhero.com
833-338-0299
investors@perklabs.io
4.000 tests / 175 $ daily = 700.000 $
by @accesswire on 27 Apr 2021, 03:30
Empower Clinics Launches Direct-To-Consumer E-Commerce Solutions
Convenient at-home saliva COVID-19 tests available now
VANCOUVER, BC / ACCESSWIRE / April 27, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, telemedicine platforms and a highly complex medical diagnostics laboratory processing thousands of COVID-19 specimens - officially launched its direct-to-consumer (DTC) e-commerce solutions in partnership with industry leader The Snow Agency.
Starting today Empower patients, both existing and prospective, can access an accessible, seamless and educative online experience when purchasing at-home diagnostics test kits. U.S. patients can purchase Kai Care's at-home COVID-19 saliva test kits with same-day shipping at www.kaitests.com. Canadian e-commerce options via www.kaitests.ca will be available in the near future.
"Empower is committed to making access to our products as convenient as possible to all patients in North America. A DTC e-commerce solution is a key part of that solution," said Steven McAuley, Chairman & CEO of Empower. "With The Snow Agency as our outstanding digital marketing partner, we're providing innovative and convenient at-home testing solutions to more patients looking to take control of their health data. Our labs at Kai Medical process up to 4,000 tests a day, screened by highly capable scientists and medical professionals. While vaccines are key, this increased testing instills trust and confidence to help everyone resume their normal lives as safely as possible.
"With COVID-19, speed matters. Today's e-commerce launch of Kai Care connects accessible health care and convenience so you and your loved ones can get both a COVID-19 test and your results in record time. Collaborating with Empower to help reopen the economy, allow people to travel, and feel safe in their communities is a partnership we're so proud to be a part of," said Dan Snow, CEO and Co-founder of The Snow Agency.
"As a trained medical professional and a digital marketing entrepreneur, I know this tool will give patients the confidence to take control of their health and wellness. Today's e-commerce launch is one step closer to putting COVID-19 in our collective rear-view mirror so we can get back to enjoying events and get-togethers of all shapes and sizes. Steven and his team have a fantastic vision for KaiTests.com that's built on knowledge and empathy. We're thrilled to be a part of the solution." said Dr. Jonathan Snow, COO and Co-founder of The Snow Agency.
The next phase of the collaboration between Empower and The Snow Agency will focus on educational, simple, and fun digital campaigns to create awareness about Kai Care's ground-breaking testing solutions, starting with their at-home COVID-19/Influenza saliva test kit. To learn more about the test, visit www.kaitests.com.
The Snow Agency is a performance digital marketing and creative agency whose customized brand strategies and content production maximize the impact of direct response ads and creatives on Facebook/Instagram, Google/YouTube, Snapchat, and Email/SMS. To date, they've brought in more than $250 million USD in sales for their clients. The Snow Agency has been recognized on Yahoo! Finance ranked as the #1 US Digital Marketing Agency & Digital Agency in January 2021 by Design Rush, a top B2B marketplace connecting brands with agencies.
This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics
ABOUT EMPOWER:
Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley
Chief Executive Officer
CONTACTS:
Investors:
Steven McAuley CEO
s.mcauley@empowerclinics.com
604-789-2146
Investors:
Tamara Mason
Business Development & Communications
t.mason@empowerclinics.com
416-671-5617
by @accesswire on 13 Apr 2021, 09:36
Empower Appoints Kai Medical Laboratory President Yoshi Tyler To Board of Directors
Kai Medical Laboratory, a state-of-the-art diagnostics laboratory in Dallas, was acquired by Empower Clinics on October 6, 2020 to further advance the Company's COVID-19 national testing programs for enterprise clients, including movie and television studios, businesses and travel industry
VANCOUVER, BC / ACCESSWIRE / April 13, 2021 / EMPOWER CLINICS INC. (CBDT:CSE) (8EC:Frankfurt) (EPWCF:OTCQB) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens - is pleased to announce it has appointed Ms. Yoshi Tyler to its board of directors.
With a professional and entrepreneurial background in healthcare, Ms. Tyler has more than 13 years of experience providing leadership at Pfizer, Inc., a Fortune 500 pharmaceutical company. This experience has provided her with in-depth knowledge and industry insights to found and lead Kai Medical Laboratory towards unprecedented growth. Empower fully acquired Kai Medical Laboratory in October 2020.
"We are delighted to welcome Yoshi as a valued addition to our board of directors," said Steven McAuley, Chairman & CEO of Empower. "Having diverse leadership continues to improve our company and since our acquisition of Kai Medical Laboratory, Yoshi has led her team to surpass initial growth forecasts and demonstrated an incredible work ethic and passion for excellence. I am privileged to now count Yoshi as a fellow board member in recognition of her talent, performance and passion."
"I'm thrilled to be contributing to the growth of Empower at another level of the company," said Yoshi Tyler. "After only a few months as part of the Empower team, I've witnessed the benefits of our synergies and know firsthand about the incredible potential we have to become a leading integrated health care company in North America."
This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics
ABOUT EMPOWER:
Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley
Chief Executive Officer
CONTACTS:
Investors:
Steven McAuley CEO
s.mcauley@empowerclinics.com
604-789-2146
Investors:
Tamara Mason
Business Development & Communications
t.mason@empowerclinics.com
416-671-5617
Apr 9, 2020
Digital health and CBD are propelling Empower Clinics forward
https://www.bnnbloomberg.ca/digital-health-and-cbd-are-propelling-empower-clinics-forward-1.1419051
https://ceo.ca/@accesswire/empower-clinics-partners-with-leading-us-digital
by @accesswire on 8 Apr 2021, 03:35
Empower Clinics Partners with Leading U.S. Digital Marketing Agency to Launch Direct-to-Consumer e-Commerce Solutions
Snow Agency recognized as #1 U.S. digital marketing agency
VANCOUVER BC / ACCESSWIRE / April 8, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens - today announced a partnership with Snow Agency to launch its direct-to-consumer (DTC) e-commerce solutions.
https://thesnowagency.com/
The Snow Agency is a performance digital marketing and creative agency whose customized brand strategies and content production maximize the impact of direct response ads and creatives on Facebook/Instagram, Google/YouTube, Snapchat, and Email/SMS. To date, they've brought in more than $250 million USD in sales for their clients. The Snow Agency has been recognized on Yahoo! Finance ranked as the #1 US Digital Marketing Agency & Digital Agency in January 2021 by Design Rush, a top B2B marketplace connecting brands with agencies.
The collaboration will allow Empower patients, existing and prospective, to benefit from an accessible, seamless and educative experience when purchasing at-home diagnostics test kits. Today patients can purchase at-home COVID-19 saliva test kits by phone or email at www.kaitests.com.
"Empower is committed to make our solutions as convenient as possible to all patients in North America. A DTC e-commerce solution is a key part of that solution." said Steven McAuley, Chairman & CEO of Empower. "I am privileged to now count Snow Agency as a partner in our journey to deliver at-home testing solutions and empower patients to take control of their own health data. Even with vaccines, ongoing testing is desperately needed because more testing, along with mask-wearing and physical distancing, will get people back into offices, planes and classrooms and help catch cases that go undetected".
"This partnership is really making a positive difference in people's lives. We know that we can reach millions of consumers with success for brands. We see our partnership with Empower as our contribution from Snow Agency to help reopen the economy, allow people to travel with confidence and getting back to normal life." said Dan Snow, CEO and Co-founder of Snow Agency.
"As a trained physician and a digital marketing entrepreneur, I fully believe in Empower's at-home diagnostic testing solutions especially its integrated laboratory services at Kai Medical. It's the time now to digitally transform healthcare, focus on accessibility and convenience for patients and save valuable time and money on stretched public health services. People will need to get tested regularly so we can all get back to normal" said Dr. Jonathan Snow, COO and Co-founder of Snow Agency.
This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics
ABOUT EMPOWER:
Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley
Chief Executive Officer
Empower Clinics Reports Q1 2021 Patient Results With Year Over Year Growth of 460%
Patient count for March increased by 388%
VANCOUVER BC / ACCESSWIRE / April 7, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(FRA:8EC)(OTCQB:EPWCF) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens, is pleased to announce that patient counts increased by 460% in Q1 2021 (26,317) versus Q1 2020 (5,717). Patient counts for the month of March increased by 388% versus the same period in 2020 with total patient counts of 8,379 in March 2021 compared to 2,160 in March 2020.
"The delivery of world-class patient care is the number one priority for our team in all the markets we serve." said Steven McAuley, Chairman & CEO of Empower. "I am so proud of our members' daily effort and dedication to patients even in such uncertain times. For our team to achieve such significant year-over-year growth numbers is a testament to our ability to execute on our business plan to acquire patients and drive long-term shareholder value. I'm especially proud of the strong growth in the last month of Q1 which sets us up for continued growth in Q2 2021"
The Company has also issued a total of 800,000 stock options priced at $0.57 CAD to investor relation service providers and to a Director of the Company.
This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics
ABOUT EMPOWER:
Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley
Chief Executive Officer
CONTACTS:
Investors:
Steven McAuley CEO
s.mcauley@empowerclinics.com
604-789-2146
Investors:
Tamara Mason
Business Development & Communications
t.mason@empowerclinics.com
416-671-5617
Don't worry Lao, we're all still here.
Long is long when you know what that means.
You won't get rid of us that fast.
Empower Clinics
To Da Moon
great NEWS
Empower Clinics KAI Medical Laboratory Annual Revenue Run Rate Now Exceeding $10,000,000 USD. Empower Anticipates Order For Next 50,000 KAI Saliva PCR Test Kits To Prepare For Demand
https://marketwirenews.com/news-releases/empower-clinics-kai-medical-laboratory-annual-revenu-8798572318026257.html
Please due your DD ! It's your money !
Pretty impressive, a quick resume of all the efforts and activity of CBDT since april 1st 2020 :
Buying and Holding with Diamond Hands. Let's review the last year's PRs, shall we? 1 YR Ago, Empower had Corporate Medical Clinics in Arizona & Oregon (Sun Valley division) and a CBD manufacturing plant.
Apr 1/20 - Visits up 593% YOY for Empower's Corporate medical Clinics
Apr 13/20 - Telemedicine Health Platform is launched. 165,000 patients
Apr 17/20 - Patient visits up 480% in 2 wks
Apr 27/20 - Antibody blood draw tests offered in Arizona
May 5/20 - Corporate Patient visits up 871% YOY
Jun 2/20 - Business employee testing launched
Jun 11/20 - Starts covid testing in Oregon
Sep 10/20 - PCR testing in Arizona clinic by Kai (capacity 2,000 PCR tests in 8 hrs)
Oct 6/20 - Empower acquires Kai (4,000 PCR test capacity
Oct 7/20 - Kai testing contracts for Disney film & 5 others
Oct 19/20 - Partnership w Loop for venue tracing & travel bubble solutions w frequent PCR & Antigen testing
Oct 21/ 20 - Empower acquires 6 Clinics in Toronto (Momentum Health)
Nov 16/20 - 9,000 test order for a Film
Nov 19/20 - PCR test to differentiate Flu A/B from Covid
Nov 20/20 - Signs distribution agreement for Antigen tests w API Pharma
Dec 2/20 - FDA approves Kai Saliva PCR test
Dec 8/20 - MOU signed w SimplyFlying (Leading Aviation mkt'ing firm)
Dec 17/20 - Empower now owns 7 Clinics in Toronto. Dr Rabinowitz & Dr Tsimerman strategy to open 30 more Clinics
Jan 7/21 - Sold out 5,000 tests. Order for 25,000 more PCR tests for film, TV, & Arizona Clinics. 24 hr results.
Jan 21/21 - Plan to double Kai Lab's size. Q4 sold 6,000 tests at $150 each.
Jan 22/21 - Kai tests & Loop partnership for Golf Championship venue bubble
Feb 1/21 - Contract to provide Saliva PCR tests for Dallas Mkt Centre (5 Million sqft Wholesale Trade Centre)
Feb 9/21 - Partnership w Rexall to launch Integrated Health Centres within Rexall Pharmacies across Canada
Feb 10/21 - Secures Medical Device Establishment License (MDEL) status to sell self-administered Saliva PCR tests in Canada
Feb 16/21 - Kai surpasses 1,000 saliva PCR tests processed in 1 day. Plan to Triple Kai Lab size.
Feb 18/21 - Kai demonstrates significant validation to detect UK and S. Africa variants
Feb 25/21 - Launches 3 Integrated Health Centres: 2 in Etobikoke & 1 in London, Ontario. Each generates $2.5-3.6 Million annually. Many more Clinics are in various stages of development to open in Q2.
Mar 4/21 - Empower pays off Debt. Strong balance sheet: 13+ Medical Clinics, Kai Labs and a CBD manufacturing plant.
Reviewing this, I conclude Mgmt consistently develops business deals, contracts, new Clinics, partnerships, and expands capacity to generate revenue. Safe to conclude this growth will continue - but much more rapidly.
You can find the full news release at https://pro.ceo.ca/@accesswire/empower-clinics-receives-more-than-10500000-from
Empower Clinics Receives More Than $10,500,000 From Exercise of Warrants
Proceeds fully fund next phase of clinic rollouts, boosts processing capacity at Kai Medical and accelerates COVID-19 test revenues across North America
VANCOUVER, BC / ACCESSWIRE / March 4, 2021 / EMPOWER CLINICS INC. (CBDT:CSE)(8EC:Frankfurt)(EPWCF:OTCQB) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens - is pleased to announce the following updates demonstrating the strength of the Company's financial resources and balance sheet.
RECEIPT OF MORE THAN $10,500,000 FROM THE EXERCISE OF WARRANTS ALLOWS EMPOWER TO EXECUTE NATIONAL ROLLOUT STRATEGY
Empower is pleased to announce the receipt of in excess of $10,500,000 from the exercise of warrants up to March 1, 2021. The Company has received an additional $5,000,000 since the announcement on December 14, 2020 when the Company announced the receipt of approximately $5,500,000.
The company is in a strong financial position for continued rapid growth in its business divisions in 2021. This is a direct result of the success of the Company's execution of it's business plan as well as the expectations of continued strong revenue growth from its KAI Medical Laboratory, anticipated revenue from its national Canadian clinics rollouts and COVID-19 test kit sales over the next 12 months.
"We are in our best financial position ever and fully funded for this year's ambitious growth plan. We have paid off debt and are achieving our metrics of success across our divisions." says Steven McAuley, Chairman and CEO of Empower. "Despite any short-term stock market activity, our fundamentals remain strong and our long-term path to becoming a major North American health and wellness company is fully intact, accelerating and funded."
BALANCE SHEET FURTHER STRENGTHENED THROUGH RETIREMENT OF DEBT
The Company has paid in full outstanding long-term debt satisfying obligations to key supporters of the company.
"We are fortunate to have support from early investors, who understood our goals, had vision, knowing what it takes to develop a great company. To be able to repay our obligations to them is an honour. Our next great phase begins." said Steven McAuley, Chairman and CEO of Empower
This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics
ABOUT EMPOWER:
Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across the US and Canada. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley
Chief Executive Officer
CONTACTS:
Investors:
Steven McAuley, CEO
are there already a few dollar millionaires here?
I warned it wasn't going to be easy